Who is sponsoring NCT05256355?

NCT05256355 is sponsored by Rigshospitalet, Denmark.

What drugs are being tested in NCT05256355?

Interventions in NCT05256355: musculoskeletal ultrasound.

What condition does NCT05256355 study?

NCT05256355 studies Musculoskeletal Diseases.

Is NCT05256355 still recruiting?

NCT05256355 is currently completed. Last updated 27 October 2022.

Last reviewed 2022-10-27 · How we verify

NCT05256355

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Competency-based Assessment in Musculoskeletal Ultrasound

Completed NA Last updated 27 October 2022

What this trial tests

NA trial testing musculoskeletal ultrasound in Musculoskeletal Diseases in 30 participants. Completed in 30 June 2022.

Timeline

1 May 2022

Primary endpoint
1 June 2022

30 June 2022

Quick facts

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	30
Start date	1 May 2022
Primary completion	1 June 2022
Estimated completion	30 June 2022
Sites	1 location across Denmark

Drugs / interventions tested

musculoskeletal ultrasound

Conditions studied

Musculoskeletal Diseases — all drugs for Musculoskeletal Diseases →

Sponsor

Rigshospitalet, Denmark

Who can join

Eligibility, any sex, with Musculoskeletal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Early diagnosis and rapid treatment initiation are of most importance to prevent joint damage in patients with arthritis. Musculoskeletal ultrasound (MSUS) is becoming an integrated part of rheumatology routine care and is more sensitive than clinical examination for detecting synovitis even in the early stage of disease. However, MSUS is highly operator dependent and competences are needed to ensure correct image interpretation. Traditionally competences are evaluated on how many examinations the trainees have performed, but the gold standard has now shifted towards competency-based education where objective assessment tools are the key element. A previous study has developed a scale for assessment of ultrasound competence, The Objective Structured Assessment of Ultrasound skills (OSAUS). Although expert consensus supports evidence of content validity of the assessment instrument, it is not known if the OSAUS scale can discriminate differences in performance scores between different levels of MSUS experience in rheumatology in a reliable way.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Solid validity evidence for two tools assessing competences in musculoskeletal ultrasound: a validity study.
Carstensen SMD, Just SA, Pfeiffer-Jensen M, Østergaard M, et al · · 2024 · cited 4× · PMID 37307078 · DOI 10.1093/rheumatology/kead286

Verify or expand the search:

Other trials of musculoskeletal ultrasound

Trials testing the same drug.

NCT06562049 — Carpal Bone Erosion in Rheumatoid Arthritis :Diagnostic Value · not yet recruiting
NCT04435730 — Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients · completed

Other recruiting trials for Musculoskeletal Diseases

Currently open trials in the same condition.

NCT07324655 — Association Between Office Ergonomics, Work Organization, and Musculoskeletal Complaints in Medical Secretaries · recruiting
NCT07004478 — Turkish Adaptation Study of the Generic Functional Index · recruiting
NCT06461000 — EULAR Impact of Rheumatic and Musculoskeletal Diseases Survey · recruiting
NCT07088965 — Musculoskeletal Disorders of Postgraduate Dentistry Students and Specialist Dentists · recruiting
NCT06175871 — New Clinical Rehabilitation Approach for the Management of Falls Risks · NA · recruiting

Other Rigshospitalet, Denmark trials

Trials by the same sponsor.

NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05256355 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
Last refreshed: 27 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05256355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing